🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Sickle Cell Anemia in Children

Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa NCT05285917Phase 31 site📍 Luanda Brown University · Tests: Hydroxyurea Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study NCT07708714Phase 1, Phase 21 site📍 Kampala Children's Hospital Medical Center, Cincinnati · Tests: hydroxycarbamide Pressure Pain Tolerance in Relation to Balance and Strength in Children NCT06529874NA1 site📍 Giza Adly A Adam · Tests: Pressure pain tolerance measurement using Digital Pressure Algometer, Balance assessment using HUMAC balance system, Lo… Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease NCT02675959Phase 24 sites📍 Los Angeles📍 Gainesville📍 Valhalla New York Medical College · Tests: Defibrotide Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA NCT06581900n/a1 site📍 Reims CHU de Reims · Tests: Vitamin B12 A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia NCT06609226Phase 3107 sites📍 Birmingham📍 Phoenix📍 Los Angeles Novo Nordisk A/S · Tests: Etavopivat A, Etavopivat B, Etavopivat C Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease NCT03353584NA2 sites📍 Memphis📍 Memphis St. Jude Children's Research Hospital · Tests: Virtual Reality Therapy Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults NCT07369024Phase 21 site📍 Torrance Mohsen Saidinejad · Tests: Sub-dissociative Ketamine Infusion, Normal Saline Placebo Infusion Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease NCT06578507Phase 27 sites📍 Créteil📍 Jossigny📍 Le Kremlin-Bicêtre Theravia · Tests: Hydroxycarbamid Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease NCT03587272Phase 27 sites📍 Washington D.C.📍 Chicago📍 New York Robert Nickel · Tests: Alemtuzumab, low dose total body irradiation, Sirolimus Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease NCT07356050n/a3 sites📍 Cincinnati📍 Accra📍 Mwanza Children's Hospital Medical Center, Cincinnati Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease NCT07247188Phase 37 sites📍 Atlanta📍 Atlanta📍 Omaha Sanofi · Tests: PCV21, 20vPCV Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders NCT03128996Phase 1, Phase 24 sites📍 New Haven📍 Wilmington📍 Grand Rapids Washington University School of Medicine · Tests: RIC regimen, GVHD prophylaxis regimen Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor NCT03214354Phase 21 site📍 Calgary University of Calgary · Tests: Alemtuzumab, Total Body Irradiation, Sirolimus Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children" NCT06735625NA1 site📍 Saint-Denis Centre Hospitalier de Saint-Denis · Tests: Measurement of AHSP concentration PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] NCT06923111n/a12 sites📍 Hamburg📍 Heidelberg📍 Basildon Nova Laboratories Limited · Tests: Xromi Functional Ovarian Reserve in Sickle Cell Disease NCT07392216n/a1 site📍 Memphis St. Jude Children's Research Hospital Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease NCT07001631NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Eye Movement Desensitization and Reprocessing (EMDR) Exploratory Study on Global Reflexology in Sickle Cell Disease NCT06619197NA1 site📍 Bron Hospices Civils de Lyon · Tests: Global reflexology Stroke Prevention in Nigeria 2 Trial NCT06526117Phase 42 sites📍 Kano📍 Kano Vanderbilt University Medical Center · Tests: Hydroxyurea Cerebral Oxygen Metabolism in Children NCT04157179NA1 site📍 St Louis Washington University School of Medicine · Tests: Carbon Dioxide Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease NCT02447874Phase 1, Phase 22 sites📍 Atlanta📍 Atlanta Emory University · Tests: Arginine, Arginine (Loading), Arginine (Continuous) Exercise in Child Health NCT05359991NA1 site📍 Irvine University of California, Irvine · Tests: Exercise
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy